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Summary: A radioimmunoassay (RIA) without chromatography for the determination of 5a-androstan-3a,17j3-diol
and of 5a-androstane-3(3,17/3-diol in human plasma by using highly specific antisera against the 15/3-carboxyethyl-
mercapto-bovine serum albumin conjugates is described. It could be shown that the 13% cross reaction of the
5a-androstane-3/3,17/3-diol antiserum with pure androst-5-ene-3/3,17/3-diol was negligibly low in plasma extracts.
Sensivity, accuracy, precision, and linearity revealed results which comply with the requisites of a reliable RIA. The
plasma levels obtained were as follows (mean ± SD): 5a-androstan-3a, 17/3-diol: Normal males (N = 27) 0.86 ±
0.22 nmol/1; normal females (N = 10) 0.31 ± 0.07 nmol/1; hirsute females (N = 25) 0.60 ± 0.24 nmol/1; 5a-androstane-
3/3,170-diol: Normal males 1.47 ± 0.43 nmol/1; normal females 0.49 ±0.10 nmol/1; hirsute females 0.91 ±
0.32 nmol/1.
Unkonjugiertes 5a-Androstan-3a, l Jfrdiol und 5a-Androstan-3ß, 17ß-diol im Plasma des Menschen,
mit Radioimmunoassay ohne Chromatographie bestimmt
Zusammenfassung: Es wird ein Radioimmunoassay ohne Chromatographie zur Bestimmung von 5a-Androstan-3a,
17j3-diol und 5a-Androstan-3/3,17/3-diol im menschlichen Plasma beschrieben. Er basiert auf hoch-spezifischen Anti-
sera gegen die ISß-Carboxyethylmercapto-Rinderserumalbumin-Konjugate dieser Steroide. Die 13 %ige Kreuzreaktion
des 5a-Androstan-3/3,17j3-diol-Antiserums gegen reines Androst-5-en-3/3,17/3-diol war extrem niedrig mit Plasma-Extrak-
ten. Empfindlichkeit, Richtigkeit, Genauigkeit und Linearität entsprechen den Kriterien eines zuverlässigen RIA. Die
gemessenen Plasma^Konzentrationen waren folgende ( ± s): 5a-Androstan-3a, 17/3-diol: Normale Männer (N = 27)
0,86 ± 0,22 nrnol/l; normale Frauen (N = 10) 0,31 ± 0,07 nmol/1; hirsute Frauen (N = 25) 0,60 ± 0,24 nmol/1;
5a-Androstan-3/3, 17/3-diol: Normale Männer 1,47 ± 0,43 nmol/1; normale Frauen 0,49 ±0,10 nmol/1; hirsute Frauen
0,91 ± 0,32 nmol/1.
Introduction Material and Methods
Owing to the increasing interest in the metabolism of All reagents were analytical grade and used without further
n^hydroxy-Sa-androstan-S-one in androgenic target fi^HisT-androstan-Ba, I7*diol (spec, activity 1.48 to
organs, the development of a simple and specific proce- 2 22 TBq/mmol) and ri,2-3H]androst-5^ne-3^ 170-dioi (spec.
(Jure for the estimation of the two important meta- iaictivity 1.48 to 2.22 TBq were obtained from NEN (Dreieich,
bolites of 17ßihydroxy.5a-andröstan,3,one, Sarandrostan- F-R-G.). [l,2-3Hi5a-androstane-3ß,17ß-diol (spec, activity
x ! « / > , . , J r ^ j . *a 110 · - · 1.48 to 2.22 TBq/mmol) was purchased from Amersham-Buchler3 , 17/tdiQl and 5a-androstane-3ß, 17/3-diol, in plasma (Braunschweig, F.R.G.). The purity of labelled steroids was
Was attempted. The methods published SO far (for checked every 6 weeks. Non-labelled steroids were purchased
references see discussion) need Chromatographie steps from Steraloids (Wilton, U.S.A.).
for separating cross reacting steroids. This disadvantage Antisera against the 150-carboxyethylmercapto-bovine serum
was overcome by-using **& antisera raised against ^^^^^^^^^^ of Dr. Rao
the 150-carboxyethylmercapto-bovine serum albumin (§an Antonio, U.S.A.).
conjugates of 5a-androstan-3a, 170-diol and 5a-androstane- A RIA was ad^ptgd for the estimation of Sa-androstan-S«,!?/?-
30,17/3-diol (1). The methodological details are described diol and 5ot-androstane-3^, 17^-diol in plasma. The details of the
in this paper. met*od « as follows:
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To 2 ml heparinized plasma, 10 ìÀ of an ethanolic solution of
(3H15a-androstan-3<*, 170-diol (33.3 Bq) were added, followed
by an extraction with diethyl ether (10 volumes per volume).
The aqueous phase was frozen at - 18 °C and the ether siphoned
off and evaporated under nitrogen. The residue was dissolved
in 2.2 ml physiological saline and 150 ìÀ were used for the
recover}' determination. Duplicate estimations of 3á- and
30-diol were performed in 500 ìÀ samples. To each 500 ìÀ
specimen, 500 ìÀ of a physiological saline solution of (3H|5a-
androstan-3a,170-diol or (3H]5a-androstane-3p,17j3-diol
(333 Bq), respectively, were added together with 250 ìÀ of the
respective 5a-androstan-3a, 17/3-diol or 5a-androstane-30,170-diol
antiserum dissolved in a solution of bovine serum albumin
(1 g/1 (working titer 1:8000). The period of incubation at 4 °C
was 16 hours. Separation of free and bound steroid moieties
was achieved by the addition of 200 ìÀ of a charcoal/dextran
solution (500 mg/100 ml charcoal; 50 mg/100 ml dextran;
100 mg/100 ml -y-globulin in physiological saline). The mixture
was incubated for 20 minutes at 4 °C, and thereafter centrifuged
for 6 minutes (2000 #). The supernatant was transferred into
counting vials and to each sample 10 ml Insta-Gel® (Packard)
were added.
Scintillation counting was accomplished by means of a Beta-
szint-5000 (Berthold, Wildbad, F.R.G.) on-line with a Diehl
Alphatronic desk computer (tolerated error less than 8%).
Standard curves were prepared in triplicate for each series of
determinations, using 0 to 1500 pg of the respective non-labelled
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Fig. 1. Standard curve (mean ± SD) of 5a-androstan-3a,17 -diol
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Fig. 2. Standard curve (mean ± SD) of 5a-androstane-30,17/3-diol
obtained from 11 curves within 8 weeks.
Epoxidation ofandrost-5-ene-3 , 17 -diol
The method reported by Lisboa (2) was used with slight modifica-
tions. Ethanolic solutions containing 1000 pg of cold 5a-andro-
stane-3/3,170-diol and androst-5-ene-3/3,170-dioI, respectively,
were evaporated to dry ness and 1 ml of p-nitroperbenzoic acid in
diethyl ether added (10 g/1). The solution was left for 17 hours
at room temperature and thereafter diluted with 5 ml diethyl
ether and washed by sucessive addition of 2 ml of a sodium
bicarbonate solution (100 g/1), 3 X 2 ml redistilled water and
1.5 ml of a saturated NaCl solution. The diethyl ether phase was
evaporated to dry ness and redissolved in physiological saline for
5ot-androstane-3j3,17/3-diol RIA as described in the foregoing sec-
tion. [3H)5cKindrostane-30,17|3-diol, [3H)androst-5-ene-3/3,17/3-
diol and mixtures of both steroids in ethanol (33.3 Bq) were
brought to dry ness and treated with p-nitroperbenzoic acid in the
manner described above. The final residue was separated by TLC
(cyclohexane/ethyl acetate; 40-ml + 60 ml) and scanned by
means of a Beta-camera (Berthold, Wildbad, F.R..G.).
Paper chromatography
In order to separate 5a-androstane-3/3,17|3rdiol and androst-5-ene-
30,17 -diol, the Bush A system (heptane/methanol/water; 50 ml
+ 40 ml + 10 ml) was used (running time 30 h at 27 °C; Schlei-
cher and Schull paper 2043b). The location of the steroids was
achieved by labelled standards (333 Bq) placed on parallel strips
and scanning with a Berthold paperscanner. The corresponding
sections of the strips containing the plasma extracts were cut put
and eluted with methanol. 5a-andrpstane-3/3,170-diol RIA was
performed on the dried residues as outlined above.
Statistics




The extremely high specificity of the 5a-androstan-3a,
17/kliol antiserum reported by Rao et al. (1) could be
confirmed by control experiments in our laboratory.
Moreover, the low cross-reaction with androsterone of
1.22% was found to be less than 1% in our experiments.
The 5a-androstane-3/J, 17/3-diol antiserum also proved to
be remarkably specific. The data of cross-reactions with
5o:-dihydrotestosterone (1.25%), testosterone (0.38%),
oestradiol-17/3 (1.35%), and oestriol (0.11%) published
by Rao et al. (1) turned out to be half as high on average.
The list of tested compounds has been completed in that
also the 17a-hydroxy-isomers of the androstane-diols
(0.13%) and the 5á,6á epoxy derivative of 5a-androstane-
3/3,17/3-diol (0%) were included. However, the cross-reac-
tion with androst-5-ene-3/3,17/3-diol amounted to 13%
in our experiments compared to 15.27% found by Rao
et al (1). Therefore, efforts have been made to remove
this interfering steroid. For this purpose the epoxidation
by treatment withp-nitroperbenzoic acid (2) was chosen.
Excellent results were obtained with pure [3H]5a-andro-
stane-3/3,17j3-uiol and [3H]androst-5-ene-3/3,17/3-diol,
99,5% of [3H]androst-5-ene-3/3,17/3,diol being converted
to [3H]5a,6a^poxy-androstane-3/3,17/3-diol, wereas the
[3H]5a-androstane^3/3,17/3-diol remained unaffected as
could be shown fey TLC: However, the plasrp# extracts
contained unknown impurities following the epoxidation
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Tab. 1. Mean concentration of 5a-androstane-3j8,17/3-diol
extracted from a male plasma pool.
A = RIA without chromatography
B = RIA following separation of androst-5-ene-30,170-diol
by paper chromatography.
Tab. 2. Mean values of recovered 5<x-androstan-3a, 170-diol and
5 a-androstane-30,17/3-diol from preextracted male plasma
(N = 4).
Number of samples
Mean (nmol/1) ± SD
Coefficient of variation (%)
A B
5 5
1.09 ±0.09 1.04 ±0.11
8.3 10.4
reaction which made it impossible 'to get correct displace-
ment curves. Therefore, experiments were carried out to
compare the 5a-androstane-3/3, 17/3-diol RIA with extracts
from male plasma before and after separation of
5a-androstane-3/J, 17/J-diol and androst-5-ene-3/3, 17/3-diol.
The separation of the two 3/3-hydroxy-steroids by paper
chromatography in the System Bush A was excellent
(running distance 9.3 and 1 1 .8 cm, respectively). The
results of the RIA performed with five respective plasma
samples are demonstrated in table 1 . It is apparent that
after chromatography the concentration of 5a-andro-
stane-3/3, 17/3-diol was 96% of that determined "directly".
This insignificant difference encouraged us to carry out
the 5a-androstane-3/3, 17/3-diol RIA also without preced-
ing chromatography. The steroid concentration eluted
from the androst-5-ene-30, 170-diol spots and estimated
with the 5a-androstaneO/3, 17/3-diol, an tiserum amounted
to 0.03 nmol/1.
Sensitivity
The sensitivity was estimated using the formula of
Abraham (3):
were R is the percent recovery, F is the fraction of the
recovered steroid used in the assay, and SD is the stand-
ard deviation of the mean of quadruplicate blank values.
The blank values for 5<*-androstan-3a, 17/3-diol RIA
were ÷ 2.31 ± 4.3 pg (N - 15) and the sensitivity 7.0 pg;
the corresponding figures for the 5a-androstane-3/3,
17/3-diol RIA were ÷ 0.73 ± 2.2 pg and 3.0 pg. Figures 1
and 2 show the mean standard curves (± SD) for
5a-androstan-3a,17/3- and 5a-androstane-3/3, 17/3-diol,
obtained from 10 different curves within a period of
8 weeks.
Accuracy
33.3 Bq of [3H]5a-androstan-3a,17/Hiol were added
to 37 samples of preextracted female plasma. The
recovery was found to be X 92.1% ± 9.05 (SD) and the
coefficient of variation (CV) calculated to be 9.82%. The
corresponding data for [3H]5a-androstane-3/3, 17/3-diol
using the same procedure were ÷ 92.9% ± 8.95;
CV 9.63%. To four preextracted plasma samples, differ-
ent amounts of non-labelled 5a-androstan-3a, 17/3-diol
and 5a-androstane-3/3, 17/3-diol were added. The results



































recovery of low and high concentrations revealed some-
what better results with the 5a-androstane-3/3,17/3-diol
antiserum. The figures show clearly that no cross-reac-
tion between 5a-androstan-3a, 17/3-diol and 5a-androst-
ane-3/3, 17/J-diol existed.
Precision
Calculation of the intra-assay variation of the 5a-andro-
stan-3a, 17/3-diol RIA yielded the following results (mean
± SD): 0.18 ± 0.02 nmol/1; CV = 9.31% (N = 10) and
0.42 ± 0.02 nmol/1; CV = 5.54% (N = 7). The correspond-
ing data for the 5a-androstane-3/3,17/3-diol RIA were as
follows: 0.39 ± 0.03 nmol/1; CV = 8.59% (N = 10) and
1.08 ± 0.07 nmol/1; CV = 6.21% (N = 8). The inter-assay
variation of the 5a-androstan-3a, 17/3-diol RIA came to
0.34 ± 0.03 nmol/1; CV = 8.15% (N = 8) and of the
Sa-androstane-3/3,17/3-diol RIA to 0.56 ·± 0.04 nmol/1;
CV = 6.41%(N = 8).
Linearity
In seven different aliquots (20 to 150 ìÀ) of a male
plasma pool, 5a-androstan-3o:, 17/3-diol and 5a-andro-
stane-3/3,170-diol were estimated and revealed rectilinear
curves (5a-androstan-3a, 17/3-diol: r = 0.99; 5a-andro-
stane<3/3,17j3-diol:r = 1.01).
Plasma concentrations
The mean plasma levels obtained in normal adult male
and female subjects, as well as in females with idiopathic
hirsutism are compiled in table 3. The differences be-
Tab. 3. Plasma concentrations of 5a-androstan-3a,170-diol and
ScttandTQStent'Z , 17/3-diol in normal male and female
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tween males and females, and between females and
hirsutes were found to be highly significant: Males
versus females: 5a-androstan-3a, 17/3-diol p < 0.001;
5a-androstane-3j3,17/3-diol p < 0.001. Females vs.
hirsutes: 5a-androstan-3a, 17/3-diol p < 0.01; 5a-andro-
stane-30,17/3-diol p < 0.001.
Discussion
5a-androstan-3o:, 17/3-diol
The high specificity of the 5a-androstan-3a:, 17/3-diol
antiserum raised by Rao et al. (1) was confirmed. The
methodological details presented fulfilled all criteria for
a reliable RIA without chromatography in plasma extracts.
Until now, no "direct" RIA for 5a-androstan-3a, 17/3-diol
in plasma has been published. The results obtained in
normal males and females correspond very well with
those reported byffabrioux et al. (4). However, the
data are higher compared than those published previously
by others (5,6,7) and from our laboratory (8), using
different types of chromatography and less specific anti-
sera. The reason for these differences remains obscure.
5a-androstane-3/3,17/3-diol
No "direct" RIA has been described hitherto for
5a-androstane-3/3, /3-diol in plasma. The specificity of
the the 5 a-androstane-3/3,17/3-diol antiserum obtained
from Rao et al. (1) seemed to be reduced owing to cross-
reaction of 13% with androst-5-ene-3j3,17/3-diol, which
has been estimated in male plasma in rather high con-
centrations ranging from 2.28 to 5.47 nmol/1 depending
upon the specificity of the antiserum and the method of
separation used (9, 10, 11, 12, 13). Unfortunately, the
removal of androst-5-ene-3/3,17/3-diol by epoxidation (2)
gave good results only with pure steroids; but introduced
unknown factors which inhibited the displacement reac-
tion with plasma extracts. It could be shown, however,
that following separation of 5a-androstane-3j3,17j8-diol
and androst-5-ene-3/3, 17/3-diol by paper chromatography
the difference between the figures before and after this
procedure was only 4%. The 5 a-androstane-3/3,17/3-diol
concentration of the androstr5-ene-3/3, 17/3-diol spots was
0.03 nmol/1. This would correspond to only 0.8% of
unconjugated androst^5-ene-3/3,17/3-diol in male plasma.
If the 5a-androstane-3/3,17/3-diol aritiserum of Rao et al.
(1) also exhibited a 13% cross-reaction with plasma
androst-5-ene-3]3,17/3-diol, the results presented in this
paper should be higher at least by 0.5 nmol/1 in males
and by 0.27 nmol/1 in females. Obviously, the cross-reac-
tion with plasma androst-5-ene-3/3,17/3-diol is negligibly
low. Similar results were obtained in plasma drawn from
spermatic vein (unpublished). The conclusion can be
drawn that in some instances the cross-reaction of a
steroid estimated with added pure steroid does not
necessarily correspond with the cross^reaction of the
same steroid extracted from plasma. This statement is
confirmed by comparing the results described above
with those reported in the literature which are markedly
higher: Hopkinson et al. (14) found 2.08 and 0.97 nmol/1
of plasma 5a-androstane-3/3,17/3-diol in males and
females, respectively. The corresponding data reported
byHabrioux et al. (4) were 2.79 and 1.76 nmol/1. Regard-
ing sensitivity, accuracy, precision, and linearity the
5a-androstane-3/3,17/3-diol RIA met all requirements of a
reliable method. Therefore, both antisera of Rao et al.
(1) are suitable tools for a "direct" RIA of 5a-androstan-
3 , 17/3-diol and 5 a-androstane-3/3,17/3-diol in human
plasma.
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